Sort
64,565 grants matching “drug discovery”
Megalencephaly and segmental brain overgrowth in humans
$666,161Kathleen Joyce Millen · Seattle Children'S Hospital · R01 · FY2019 · NS
Pathway Hypotheses Knowledge-base: A Knowledge Source for the Biomedical Data Translator
$666,063Eugene Santos · Dartmouth College · OT2 · FY2021 · TR
Mechanism Based Inhibition of M Tuberculosis Enzymes
$666,048John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2009 · AI
ID. of Pathways that can be Targeted for the Develop. of Novel Therapies for MRSA
$665,993Eleftherios Mylonakis · Massachusetts Eye And Ear Infirmary · P01 · FY2012 · AI
Exonic variants and their relation to complex traits in minorities of the WHI
$665,846Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2014 · HG
MicroRNA Control of Dilated Cardiomyopathy
$665,737Mark Mercola · Stanford University · R01 · FY2024 · HL
Skeletal Muscle Fibrosis and Progesterone Receptor
$665,718Serdar E Bulun · Northwestern University At Chicago · R01 · FY2025 · DK
Molecular pathways affected by drugs that disrupt Na+ and lipid homeostasis in malaria parasites
$665,638Akhil B Vaidya · Drexel University · R01 · FY2025 · AI
Development of Yeast-Based Assays for anti-influenza drug discovery
$665,597Daniel A Engel · University Of Virginia · R01 · FY2006 · AI
Protein Tyrosine Dephosphorylation & signal Transduction
$665,593Nicholas K Tonks · Cold Spring Harbor Laboratory · R37 · FY2007 · CA
Engineered Stem Cells for Cardiac Repair
$665,587Michael Regnier · University Of Washington · R01 · FY2021 · HL
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users
$665,484Luis J. Montaner · Wistar Institute · R01 · FY2011 · DA
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users
$665,385Luis J. Montaner · Wistar Institute · R01 · FY2010 · DA
Tissue ProcessingSequencing Core
$665,306Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children
$665,257Paul W. Burridge · Northwestern University At Chicago · R01 · FY2022 · CA
Lab Research Training in Pediatric Oncology-Hematology
$665,090Alan D Friedman · Johns Hopkins University · T32 · FY2024 · CA
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML
$664,967Ann-Kathrin Eisfeld · Ohio State University · R01 · FY2022 · CA
Case GI SPORE
$664,839Sanford D Markowitz · Case Western Reserve University · P50 · FY2022 · CA
Microbial Ecology-Guided Discovery of Antibacterial Drugs
$664,819Eric W Schmidt · University Of Utah · R01 · FY2022 · AI
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$664,692Thomas E Ferrin · University Of California, San Francisco · R01 · FY2022 · GM
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$664,692Thomas E Ferrin · University Of California, San Francisco · R01 · FY2025 · GM
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$664,692Thomas E Ferrin · University Of California, San Francisco · R01 · FY2023 · GM
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$664,692Thomas E Ferrin · University Of California, San Francisco · R01 · FY2024 · GM
Discovery and Analysis of Synthetic TLR Agonists and Antagonists
$664,650Bruce A Beutler · Scripps Research Institute, The · U24 · FY2009 · AI
Catalytic Oxidations for Pharmaceutical Synthesis
$664,629Shannon S Stahl · University Of Wisconsin-Madison · R35 · FY2021 · GM